Mar. 11, 2025
DUBLIN, IRELAND – Neuromod Devices Ltd. (Neuromod), an Irish medical device company specializing in tinnitus treatment, has successfully closed a €10 million (~$10.9M USD) equity financing to expand the availability of its tinnitus treatment device, Lenire. Oversubscribed Financing to Support Growth Neuromod raised €10 million ($10.9 million) in an expansion of its Series B funding round. The financing was oversubscribed

















